What is Zacks Research’s Forecast for CLB FY2027 Earnings?

Core Laboratories Inc. (NYSE:CLBFree Report) – Zacks Research reduced their FY2027 earnings estimates for Core Laboratories in a research note issued on Friday, July 17th. Zacks Research analyst Team now expects that the oil and gas company will earn $0.80 per share for the year, down from their previous forecast of $0.82. The consensus estimate for Core Laboratories’ current full-year earnings is $0.53 per share.

Core Laboratories (NYSE:CLBGet Free Report) last announced its quarterly earnings data on Wednesday, April 29th. The oil and gas company reported $0.06 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.06. Core Laboratories had a net margin of 5.94% and a return on equity of 11.52%. The firm had revenue of $121.80 million for the quarter, compared to the consensus estimate of $122.99 million. During the same period in the prior year, the company posted $0.14 earnings per share. The business’s revenue for the quarter was down 1.4% on a year-over-year basis. Core Laboratories has set its Q2 2026 guidance at 0.060-0.120 EPS.

A number of other research analysts have also recently issued reports on the stock. Wall Street Zen cut shares of Core Laboratories from a “hold” rating to a “sell” rating in a research note on Saturday, July 4th. Weiss Ratings cut Core Laboratories from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, June 24th. One research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Core Laboratories presently has a consensus rating of “Reduce”.

Check Out Our Latest Stock Report on Core Laboratories

Core Laboratories Stock Performance

Shares of Core Laboratories stock opened at $11.31 on Monday. The company has a 50 day moving average of $12.51 and a 200-day moving average of $15.66. Core Laboratories has a 1-year low of $9.72 and a 1-year high of $20.36. The company has a current ratio of 2.05, a quick ratio of 1.50 and a debt-to-equity ratio of 0.42. The company has a market cap of $521.59 million, a PE ratio of 17.41, a price-to-earnings-growth ratio of 2.74 and a beta of 1.00.

Institutional Trading of Core Laboratories

A number of hedge funds have recently added to or reduced their stakes in CLB. Summit Securities Group LLC acquired a new position in shares of Core Laboratories during the first quarter worth $31,000. Aster Capital Management DIFC Ltd bought a new position in shares of Core Laboratories in the 4th quarter valued at $34,000. CWM LLC boosted its holdings in shares of Core Laboratories by 36.1% during the 4th quarter. CWM LLC now owns 2,516 shares of the oil and gas company’s stock valued at $40,000 after acquiring an additional 668 shares in the last quarter. Quarry LP boosted its holdings in shares of Core Laboratories by 118.1% during the 3rd quarter. Quarry LP now owns 2,953 shares of the oil and gas company’s stock valued at $36,000 after acquiring an additional 1,599 shares in the last quarter. Finally, Hantz Financial Services Inc. boosted its holdings in shares of Core Laboratories by 124.7% during the 4th quarter. Hantz Financial Services Inc. now owns 3,177 shares of the oil and gas company’s stock valued at $51,000 after acquiring an additional 1,763 shares in the last quarter. Institutional investors and hedge funds own 97.81% of the company’s stock.

Core Laboratories Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, June 1st. Investors of record on Monday, May 11th were paid a $0.01 dividend. The ex-dividend date of this dividend was Monday, May 11th. This represents a $0.04 annualized dividend and a yield of 0.4%. Core Laboratories’s dividend payout ratio is presently 6.15%.

About Core Laboratories

(Get Free Report)

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.

Featured Articles

Earnings History and Estimates for Core Laboratories (NYSE:CLB)

Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.